Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Docetaxel 20mg/1ml solution for infusion vials
0801050D0AAACAC
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 20mg/2ml solution for infusion vials
0801050D0AAAEAE
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/2.88ml inf vials and diluent
0801050D0AAAMAM
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/2ml solution for infusion vials and diluent
0801050D0AAABAB
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/4ml solution for infusion vials
0801050D0AAADAD
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Docetaxel 80mg/8ml solution for infusion vials
0801050D0AAAFAF
|
Docetaxel | Docetaxel | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin (liposomal) 50mg inf vials
0801020K0AAAHAH
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg powder for solution for injection vials
0801020K0AAAAAA
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/2ml solution for injection vials
0801020K0AAAIAI
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/5ml solution for injection Cytosafe vials
0801020K0BCAEAC
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/5ml solution for injection vials
0801020K0AAACAC
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 200mg/100ml inj Cytosafe vials
0801020K0BCAGAJ
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 200mg/100ml solution for infusion vials
0801020K0AAAJAJ
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg powder for solution for injection vials
0801020K0AAABAB
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg/25ml solution for injection Cytosafe vials
0801020K0BCAFAD
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg/25ml solution for injection vials
0801020K0AAADAD
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin pegylated liposomal 20mg/10ml inf vials
0801020K0AAAFAF
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin pegylated liposomal 50mg/25ml inf vials
0801020K0AAAGAG
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Drogenil 250mg tablets
0803042H0BBAAAA
|
Drogenil | Flutamide | Malignant Disease and Immunosuppression | No data available |
|
Droxia 300mg capsules
0801050P0BCAAAC
|
Droxia | Hydroxycarbamide | Malignant Disease and Immunosuppression | No data available |
|
DTIC-Dome 200mg powder for solution for injection vials
0801050L0BBABAB
|
DTIC-Dome | Dacarbazine | Malignant Disease and Immunosuppression | No data available |
|
Eldisine 5mg powder for solution for injection vials
0801040Q0BBAAAA
|
Eldisine | Vindesine sulfate | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 100mg/20ml concentrate for inf vials
0801050ALBBABAB
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 200mg/40ml concentrate for inf vials
0801050ALBBACAE
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
|
Eloxatin 50mg/10ml concentrate for inf vials
0801050ALBBAAAA
|
Eloxatin | Oxaliplatin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.